Can personalised AI dosing prevent dangerous bleeding events and make warfarin therapy safer for millions?
End of Content.
Get the latest creative news from us about politics, business, sport and travel
End of Content.
Dr Tiffany Gan Rui Xuan is an endocrine surgeon and clinician-scientist at the National University Health System, Singapore. A Dean’s List graduate of NUS Yong Loo Lin School of Medicine, she is a Fellow of the Royal College of Surgeons of Edinburgh with specialist accreditation in General Surgery. Her research bridges surgery, health systems design, and medical technology innovation, with a particular focus on translating artificial intelligence into real-world clinical practice. An award-winning investigator, she is a recipient of the Young Surgeon’s Award and the Jurong Health Campus Investigator Award, and is passionate about integrating frontline patient care with advances in life sciences and healthcare technology to drive meaningful clinical impact.

Dr Tiffany Gan Rui Xuan is an endocrine surgeon and clinician-scientist at the National University Health System, Singapore. A Dean’s List graduate of NUS Yong Loo Lin School of Medicine, she is a Fellow of the Royal College of Surgeons of Edinburgh with specialist accreditation in General Surgery. Her research bridges surgery, health systems design, and medical technology innovation, with a particular focus on translating artificial intelligence into real-world clinical practice. An award-winning investigator, she is a recipient of the Young Surgeon’s Award and the Jurong Health Campus Investigator Award, and is passionate about integrating frontline patient care with advances in life sciences and healthcare technology to drive meaningful clinical impact.
Can personalised AI dosing prevent dangerous bleeding events and make warfarin therapy safer for millions?